OBJECTIVE: The aim of this study was to identify the prevalence of catecholamine excess and phaeochromocytomas in a well-defined population of people with hereditary head and neck paragangliomas. METHODS: We studied in a prospective follow-up protocol all consecutive patients referred to the Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands with documented head and neck paragangliomas and either a positive family history for paragangliomas or a proven SDHD gene mutation. Initial analysis included medical history, physical examination and the measurement of excretion of catecholamines in two 24-h urine collections. In the case of documented catecholamine excess iodinated meta-iodobenzylguanidine (123I-MIBG) scintigraphy and magnetic resonance imaging were done. RESULTS: Between 1988 and 2003, 40 consecutive patients (20 male and 20 female) with documented head and neck paragangliomas were screened. Biochemical screening revealed urinary catecholamine excess in 15 patients (37.5%). In nine of these 15 patients a lesion was found by 123I-MIBG scintigraphy. Exact localization by magnetic resonance imaging revealed phaeochromocytomas in seven of the 15 patients. One of the nine patients had an extra-adrenal paraganglioma. Histopathological examination in a subset of tumors displayed loss of heterozygosity of the wild-type SDHD allele in all cases. CONCLUSIONS: The prevalence of catecholamine excess (37.5%) and phaeochromocytomas (20.0%) is high in patients with familial head and neck paragangliomas. Therefore, patients with hereditary head and neck paragangliomas require lifelong follow up by biochemical testing for catecholamine excess.
OBJECTIVE: The aim of this study was to identify the prevalence of catecholamine excess and phaeochromocytomas in a well-defined population of people with hereditary head and neck paragangliomas. METHODS: We studied in a prospective follow-up protocol all consecutive patients referred to the Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands with documented head and neck paragangliomas and either a positive family history for paragangliomas or a proven SDHD gene mutation. Initial analysis included medical history, physical examination and the measurement of excretion of catecholamines in two 24-h urine collections. In the case of documented catecholamine excess iodinated meta-iodobenzylguanidine (123I-MIBG) scintigraphy and magnetic resonance imaging were done. RESULTS: Between 1988 and 2003, 40 consecutive patients (20 male and 20 female) with documented head and neck paragangliomas were screened. Biochemical screening revealed urinary catecholamine excess in 15 patients (37.5%). In nine of these 15 patients a lesion was found by 123I-MIBG scintigraphy. Exact localization by magnetic resonance imaging revealed phaeochromocytomas in seven of the 15 patients. One of the nine patients had an extra-adrenal paraganglioma. Histopathological examination in a subset of tumors displayed loss of heterozygosity of the wild-type SDHD allele in all cases. CONCLUSIONS: The prevalence of catecholamine excess (37.5%) and phaeochromocytomas (20.0%) is high in patients with familial head and neck paragangliomas. Therefore, patients with hereditary head and neck paragangliomas require lifelong follow up by biochemical testing for catecholamine excess.
Authors: Hans K Ghayee; Bas Havekes; Eleonora P M Corssmit; Graeme Eisenhofer; Stephen R Hammes; Zahid Ahmad; Alexander Tessnow; Ivica Lazúrová; Karen T Adams; Antonio T Fojo; Karel Pacak; Richard J Auchus Journal: Endocr Relat Cancer Date: 2008-12-15 Impact factor: 5.678
Authors: Edwin W Lai; Shiromi M Perera; Bas Havekes; Henri J L M Timmers; Frederieke M Brouwers; Beverly McElroy; Karen T Adams; Shoichiro Ohta; Robert A Wesley; Graeme Eisenhofer; Karel Pacak Journal: Endocrine Date: 2008-11-04 Impact factor: 3.633
Authors: Frederik J Hes; Marjan M Weiss; Sanne A Woortman; Noel F de Miranda; Patrick A van Bunderen; Bert A Bonsing; Marcel P M Stokkel; Hans Morreau; Johannes A Romijn; Jeroen C Jansen; Annette H J T Vriends; Jean-Pierre L Bayley; Eleonora P M Corssmit Journal: BMC Med Genet Date: 2010-06-11 Impact factor: 2.103
Authors: Erik F Hensen; Jeroen C Jansen; Maaike D Siemers; Jan C Oosterwijk; Annette Hjt Vriends; Eleonora Pm Corssmit; Jean-Pierre Bayley; Andel Gl van der Mey; Cees J Cornelisse; Peter Devilee Journal: Eur J Hum Genet Date: 2010-01 Impact factor: 4.246
Authors: Bas Havekes; Florine Kastelein; Agatha A van der Klaauw; Nicolette van Duinen; Jeroen C Jansen; Jan W A Smit; Klaas W van Kralingen; Annette H J T Vriends; Johannes A Romijn; Eleonora P M Corssmit Journal: Sleep Breath Date: 2011-05-27 Impact factor: 2.816
Authors: Erik F Hensen; Jelle J Goeman; Jan Oosting; Andel G L Van der Mey; Pancras C W Hogendoorn; Cor W R J Cremers; Peter Devilee; Cees J Cornelisse Journal: BMC Med Genomics Date: 2009-05-11 Impact factor: 3.063